TSLA is trading at $364.75 (-3.07%) at 11:08AM EST as the stock extends pressure from its $25B 2026 capex guidance amid broader market weakness.
- Analysts cite the massive spending plan for AI initiatives like Terafab and Optimus, announced in Q1 earnings, as a significant risk to free cash flow.
- With no new company-specific events today, the stock is tracking a 0.16-0.25% decline in the S&P 500 and Nasdaq.
- Broader market sentiment remains weighed down by geopolitical tensions and cautious commentary from the Federal Reserve.